ING Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-30,307
Closed -$2.42M 651
2016
Q4
$2.42M Buy
30,307
+5,840
+24% +$464K 0.05% 201
2016
Q3
$1.93M Sell
24,467
-167,680
-87% -$13.5M 0.02% 219
2016
Q2
$15M Buy
192,147
+131,464
+217% +$9.37M 0.2% 62
2016
Q1
$3.34M Sell
60,683
-117,227
-66% -$6.39M 0.04% 202
2015
Q4
$11M Buy
177,910
+129,504
+268% +$8.17M 0.07% 221
2015
Q3
$3.05M Buy
48,406
+36,688
+313% +$2.62M 0.02% 332
2015
Q2
$856K Sell
11,718
-14,573
-55% -$1.05M ﹤0.01% 532
2015
Q1
$1.72M Sell
26,291
-292,689
-92% -$19.5M 0.01% 524
2014
Q4
$20.7M Sell
318,980
-20,427
-6% -$1.32M 0.1% 201
2014
Q3
$20.4M Sell
339,407
-137,221
-29% -$8.96M 0.12% 174
2014
Q2
$33M Sell
476,628
-63,546
-12% -$4.12M 0.17% 129
2014
Q1
$35.3M Sell
540,174
-110,477
-17% -$7.19M 0.19% 127
2013
Q4
$40.3M Sell
650,651
-455,179
-41% -$26.4M 0.2% 124
2013
Q3
$59.4M Sell
1,105,830
-485,870
-31% -$25M 0.3% 79
2013
Q2
$72.7M Buy
+1,591,700
New +$69M 0.38% 69

Other funds holding STJ

ING Group's STJ Position: Q1 2017 in Review

ING Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 30,307 shares — an estimated $2.42M sold.

ING Group first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $72.7M in Q2 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • ING Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • ING Group sold 30,307 St Jude Medical shares in Q1 2017, an estimated $2.42M.
  • ING Group first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • ING Group's St Jude Medical position peaked at $72.7M in Q2 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on ING Group's 13F filing for Q1 2017, filed 1 May 2017.